Hims & Hers Health, Inc.

HIMS · NYSE · Stock · Healthcare
$27.72
-6.70% today
Delayed price,

What Hims & Hers Health does

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Key facts

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Market cap
$6.47B
P/E (ttm)
—
Forward P/E
37.6
Dividend yield
0.00%
Beta
2.43
Profit margin
-5.5%
Employees
2,442
Headquarters
San Francisco, CA, United States
Exchange
NYSE

Performance

1 Month
-1.0%
3 Months
-15.6%
6 Months
-3.8%
1 Year
-44.3%
5 Years
+323.2%
$13.7452-week range$65.30
Biggest setback — last 12 months
-70.8%
13 Oct 2025 → 23 Feb 2026
Fell from $49.78 to $14.52 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+153.4%
23 Feb 2026 → 29 Jun 2026
Ran from $14.52 to $36.80 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$21.57 (-22.2%)$27.72$35.62 (+28.5%)
3 Months$17.95 (-35.2%)$27.72$42.80 (+54.4%)
6 Months$14.99 (-45.9%)$27.72$51.24 (+84.9%)
12 Months$11.63 (-58.1%)$27.72$66.10 (+138.4%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 86.9%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.